Clearmind Medicine Inc. Adjustments For Decrease Increase In Derivative Financial Assets
Clearmind Medicine Inc. (CMND) reported Adjustments For Decrease Increase In Derivative Financial Assets of $292.39 thousand for the 9-month period ending 2025-07-31, per its 6-K filed 2025-09-11.
Financial Statements › Notes
ifrs-full:AdjustmentsForDecreaseIncreaseInDerivativeFinancialAssets · last filed 2025-09-11
CAD
| Period end | Adjustments For Decrease Increase In Derivative Financial Assets 12 month |
|---|---|
| 2022-10-31 | 396.60K CAD 20-F · filed 2023-02-06 |
USD
| Period end | Adjustments For Decrease Increase In Derivative Financial Assets 3 month | Adjustments For Decrease Increase In Derivative Financial Assets 3 month as first filed | Adjustments For Decrease Increase In Derivative Financial Assets 6 month | Adjustments For Decrease Increase In Derivative Financial Assets 6 month as first filed | Adjustments For Decrease Increase In Derivative Financial Assets 9 month | Adjustments For Decrease Increase In Derivative Financial Assets 9 month as first filed | Adjustments For Decrease Increase In Derivative Financial Assets 12 month | Adjustments For Decrease Increase In Derivative Financial Assets 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-07-31 | $63.60K derived: 6-K 9 month − 6-K 6 month · filed 2025-09-11 | $220.69K derived: sum of 2 quarters · filed 2025-09-11 | $292.39K 6-K · filed 2025-09-11 | $353.40K derived: sum of 4 quarters · filed 2025-09-11 | ||||
| 2025-04-30 | $157.08K derived: 6-K 6 month − 6-K 3 month · filed 2025-06-12 | $228.79K 6-K · filed 2025-06-12 | $289.80K derived: sum of 3 quarters · filed 2025-06-12 | $289.80K derived: sum of 4 quarters · filed 2025-09-11 | ||||
| 2025-01-31 | $71.70K 6-K · filed 2025-03-13 | $132.72K derived: sum of 2 quarters · filed 2025-03-13 | $132.72K derived: sum of 3 quarters · filed 2025-09-11 | $140.88K derived: sum of 4 quarters · filed 2025-09-11 | ||||
| 2024-10-31 | $61.01K derived: 20-F 12 month − 6-K 9 month · filed 2025-01-22 | $61.01K derived: sum of 2 quarters · filed 2025-09-11 | $69.18K derived: sum of 3 quarters · filed 2025-09-11 | $68.62K 20-F · filed 2025-01-22 | ||||
| 2024-07-31 | $0.00 derived: 6-K 9 month − 6-K 6 month · filed 2025-09-11 | $8.17K derived: sum of 2 quarters · filed 2025-09-11 | $7.61K 6-K · filed 2025-09-11 | $83.08K 6-K · filed 2024-09-16 | $237.02K derived: sum of 4 quarters · filed 2025-09-11 | |||
| 2024-04-30 | $8.17K derived: 6-K 6 month − 6-K 3 month · filed 2025-06-12 | $7.61K 6-K · filed 2025-06-12 | -$560.14K 6-K · filed 2024-06-13 | $237.02K derived: sum of 3 quarters · filed 2025-06-12 | -$245.31K derived: sum of 4 quarters · filed 2025-06-12 | |||
| 2024-01-31 | -$556.00 6-K · filed 2025-03-13 | -$155.14K 6-K · filed 2024-03-19 | $228.86K derived: sum of 2 quarters · filed 2025-03-13 | -$253.47K derived: sum of 3 quarters · filed 2025-03-13 | ||||
| 2023-10-31 | $229.41K derived: 20-F 12 month − 6-K 9 month · filed 2025-01-22 | -$252.92K derived: sum of 2 quarters · filed 2025-01-22 | $107.64K 20-F · filed 2025-01-22 | $2.19M 20-F · filed 2024-01-29 | ||||
| 2023-07-31 | -$482.33K derived: 6-K 9 month − 6-K 6 month · filed 2024-09-16 | -$121.77K 6-K · filed 2024-09-16 | ||||||
| 2023-04-30 | $360.56K 6-K · filed 2024-06-13 | |||||||
| 2022-10-31 | $308.19K 20-F · filed 2025-01-22 | $290.57K 20-F · filed 2024-01-29 |